null

SMILES: Cn1ncnc1-c1cc(ccc1Cl)[C@@H](COC(=O)NC1CC1)N1C(=N)N[C@@](CC(C)(C)C)(C1=O)c1ccc(cc1)-c1cnn(c1)C(F)F

InChI Key: InChIKey=QLKUDQVPNKOAGG-UTONBFNKSA-N

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 460904   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Envelope glycoprotein gp160 (Human immunodeficiency virus type 1 group M subtyp...)	BDBM460904 (US10774053, Compound 18) Show SMILES Cn1ncnc1-c1cc(ccc1Cl)[C@@H](COC(=O)NC1CC1)N1C(=N)N[C@@](CC(C)(C)C)(C1=O)c1ccc(cc1)-c1cnn(c1)C(F)F |r| Show InChI InChI=1S/C33H36ClF2N9O3/c1-32(2,3)17-33(22-8-5-19(6-9-22)21-14-39-44(15-21)29(35)36)28(46)45(30(37)42-33)26(16-48-31(47)41-23-10-11-23)20-7-12-25(34)24(13-20)27-38-18-40-43(27)4/h5-9,12-15,18,23,26,29H,10-11,16-17H2,1-4H3,(H2,37,42)(H,41,47)/t26-,33-/m1/s1	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.70	n/a	n/a	n/a	n/a	n/a	n/a
Gilead Sciences, Inc. US Patent					Assay Description Compounds were tested in a high-throughput 384-well assay format for their ability to inhibit the replication of HIV-1 (IIIB) in MT-4 cells. Compound...				US Patent US10774053 (2020)
					More data for this Ligand-Target Pair
Gag-Pol polyprotein (HIV-1)	US11352329, COMPD # 18 (US10774053, Compound 18) Show SMILES Cn1ncnc1-c1cc(ccc1Cl)[C@@H](COC(=O)NC1CC1)N1C(=N)N[C@@](CC(C)(C)C)(C1=O)c1ccc(cc1)-c1cnn(c1)C(F)F |r| Show InChI InChI=1S/C33H36ClF2N9O3/c1-32(2,3)17-33(22-8-5-19(6-9-22)21-14-39-44(15-21)29(35)36)28(46)45(30(37)42-33)26(16-48-31(47)41-23-10-11-23)20-7-12-25(34)24(13-20)27-38-18-40-43(27)4/h5-9,12-15,18,23,26,29H,10-11,16-17H2,1-4H3,(H2,37,42)(H,41,47)/t26-,33-/m1/s1	MMDB B.MOAD GoogleScholar AffyNet	PC cid PC sid UniChem		n/a	n/a	1.70	n/a	n/a	n/a	n/a	n/a	n/a
TBA									Citation and Details
					More data for this Ligand-Target Pair
Envelope glycoprotein gp160 (Human immunodeficiency virus type 1 group M subtyp...)	BDBM460904 (US10774053, Compound 18) Show SMILES Cn1ncnc1-c1cc(ccc1Cl)[C@@H](COC(=O)NC1CC1)N1C(=N)N[C@@](CC(C)(C)C)(C1=O)c1ccc(cc1)-c1cnn(c1)C(F)F |r| Show InChI InChI=1S/C33H36ClF2N9O3/c1-32(2,3)17-33(22-8-5-19(6-9-22)21-14-39-44(15-21)29(35)36)28(46)45(30(37)42-33)26(16-48-31(47)41-23-10-11-23)20-7-12-25(34)24(13-20)27-38-18-40-43(27)4/h5-9,12-15,18,23,26,29H,10-11,16-17H2,1-4H3,(H2,37,42)(H,41,47)/t26-,33-/m1/s1	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	9.56	n/a	n/a	n/a	n/a
Gilead Sciences, Inc. US Patent					Assay Description Assay protocol is identical to that described for the MT-4 antiviral assay with the following changes: Each drug is run in 2 series of quadruplicates...				US Patent US10774053 (2020)
					More data for this Ligand-Target Pair